Revolution Medicines Inc logo

Revolution Medicines Inc

1
NAS:RVMD (USA)   Ordinary Shares
$ 38.62 -1.12 (-2.82%) 10:08 PM EST
At Loss
P/B:
3.69
Volume:
841.66K
Avg Vol (2M):
1.16M
Trade In:
Volume:
841.66K
At Loss
Avg Vol (2M):
1.16M

Business Description

Revolution Medicines Inc logo
Revolution Medicines Inc
NAICS : 325411 SIC : 2833
ISIN : US76155X1000

Share Class Description:

RVMD: Ordinary Shares
Description
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Name Current Vs Industry Vs History
Cash-To-Debt 19.35
Equity-to-Asset 0.9
Debt-to-Equity 0.05
Debt-to-EBITDA -0.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 20.78
Distress
Grey
Safe
Beneish M-Score -6.68
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.13
9-Day RSI 43.96
14-Day RSI 48.96
6-1 Month Momentum % 42.94
12-1 Month Momentum % 48.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.45
Quick Ratio 18.45
Cash Ratio 18.18
Days Sales Outstanding 203.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -35.2
Shareholder Yield % -1.12

Financials (Next Earnings Date:2024-08-08 Est.)

RVMD's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RVMD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Revolution Medicines Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.566
EPS (TTM) ($) -3.82
Beta 1.15
Volatility % 57.34
14-Day RSI 48.96
14-Day ATR ($) 1.48572
20-Day SMA ($) 39.2705
12-1 Month Momentum % 48.04
52-Week Range ($) 15.4401 - 41.205
Shares Outstanding (Mil) 164.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Revolution Medicines Inc Filings

Filing Date Document Date Form
No Filing Data

Revolution Medicines Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Revolution Medicines Inc Frequently Asked Questions

What is Revolution Medicines Inc(RVMD)'s stock price today?
The current price of RVMD is $38.62. The 52 week high of RVMD is $41.21 and 52 week low is $15.44.
When is next earnings date of Revolution Medicines Inc(RVMD)?
The next earnings date of Revolution Medicines Inc(RVMD) is 2024-08-08 Est..
Does Revolution Medicines Inc(RVMD) pay dividends? If so, how much?
Revolution Medicines Inc(RVMD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1